Azienda Ospedaliero-Universitaria Sant Andre — Clinical Trial Site

130 Registered trials

53 Currently recruiting

Organisation

Azienda Ospedaliero-Universitaria Sant Andre

Location

Rome, Italy

Identifier

ORG-100010194

Address

Via Di Grottarossa 1035-1039, 00189, Italy

Departments

#1704:U.O.C. Malattie Apparato Digerente e del Fegato
#3656:U.O.C. di Cardiologia
1509 : U.O.C. Neurologia
3656: U.O.C. di Cardiologia
38004: U.O.C. Malattie dell'Apparato Digerente e del Fegato
3904 : UOC Malattie dell' apparato digerente
Anesthesia and Intensive Care
AOU Sant'Andre UOC Malattie dell'apparato digerente
Azienda Ospedaliero-Universitaria Sant'Andrea, UOC Medicina Specialistica Endocrino-Metabolica
Cardiologia - UTIC
Cardiology
Cardiology Unit
Cardiovascular and Respiratory Sciences
Centro Malattie Neuromuscolari – U.O.C. Neurologia
Clinica Neurologica II - Dipartimento di Scienze Neurologica
Clinical and Molecolare Medicine
Clinical and molecular medicine – Cardiology Unit
Digestive Diseases Unit
Dipartimento di Medicina Clinica e Molecolare
DIPARTIMENTO SCIENZE ONCOLOGICHE
DIPARTIMENTO SCIENZE ONCOLOGICHE - UOC EMATOLOgia
Dipartimento Scienze Oncologiche -UOC EMATOLOGIA
Division of Cardiology
Division of Cardiology, Department of Clinical and Molecular Medicine
Ematologia
Facoltà di Medicina e Psicologia
Gastroenterology
Hematology Unit
Hypertension Unit, Division of Cardiology
Internal medicine
Malattie Infettive
Medical and Surgical Sciences and Transnational Medicine
Medical Surgical Sciences and Translational Medicine - Diseases Unit
N/A
NESMOS
NESMOS Department
Neurologia
Neurologia Azienda Ospedaliero-Universitaria Sant Andrea
Neurology
Neurology and Neurophysiopathology Clinic
Neurology Unit
Neuromuscolar Disease Center
ONCO-EMATOLOGICO
Oncologia
Oncology
OUC Neurologia
Psichiatry
Psychiatry
Radiology
Radioterapia
Scienze Mediche
U.O.C. di Neurologia
U.O.C. di Psichiatria
U.O.C. Endocrinologia
U.O.C. Neurologia
U.O.C. Neuroradiologia
U.O.C. Pneumologia
U.O.C. Psichiatria
U.O.C. UOS Endocrinologia
U.O.C. UOS Endocrinologia (Endocrinology)
U.O.S Malattie Neuromuscolari
Unità di Anestesia e Terapia Intensiva
Unità Operativa Complessa di Radioterapia
Unità Operativa di Neurologia
UO Ematologia
UOC di Neurologia
UOC Cardiologia
UOC di Cardiologia
UOC Ematologia
UOC Endocrinologia
UOC Malattie dell’Apparato digerente e del fegato
UOC Medicina Fisica e Riabilitativa
UOC Medicina Interna
UOC Medicina Specialistica Endocrino-Metabolica
UOC Neurologia
UOC Neurologia, Neuromuscolar Disease Centre
UOC Neurology
UOC Oculistica
UOC Pneumologia
UOC Pulmonology
UOC Urologia
UOD Oculistica
UOS Terapia del Dolore
Urology
Via di Grottarossa 1035/39 , UOC Urologia, Roma, 00189, IT

Clinical trials at this site (130)

Search interface

A study of androgen deprivation therapy (ADT) plus apalutamide in patients with prostate cancer Ended

2023-506153-38-00 High-risk localized or locally advanced prostate cancer 5 2019-07-11
A Phase 3 study to see the benefit and safety of Luspatercept in comparison with Epoetin Alfa to treat anaemia due to very low, low or inter… Ended

2022-501485-22-00 Myelodysplastic syndrome (MDS) 5 2018-12-18
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer (monarchE) Ended

2023-509671-17-00 Breast Cancer 5 2017-07-12
Sustained treatment-free period in the course of a disease when symptoms become less severe in BCR-ABL+ chronic myeloid leukemia: a prospect… Ended

2023-510434-83-00 Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) 6 2016-10-17
An Efficacy and Safety Study of JNJ56021927 (ARN509) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS Ended

2023-505246-26-00 High- or very-high risk, localized or locally advanced 5 2016-01-27
Safety, Tolerability, and Efficacy of NVG-2089 in Participants with CIDP Ended

2024-515386-34-00 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP 4 2025-05-29
A study to evaluate safety and efficacy of Empasiprubart in adults with Dermatomyositis Ended

2023-508337-14-00 Myositis, Dermatomyositis 4 2025-03-18
Efficacy and Safety of REL-1017 for Major Depressive Disorder Ended

2023-507399-27-00 Major Depression 5 2024-12-04
A study of efgartigimod PH20 SC given by prefilled syringe in adults with thyroid eye disease Ended

2023-509198-22-00 Thyroid Eye Disease (TED) 5 2024-10-21
A study to test whether BI 1819479 improves lung function in people with idiopathic pulmonary fibrosis (IPF). Ended

2023-508395-11-00 idiopathic pulmonary fibrosis 4 2024-09-10
A study to test whether BI 1839100 improves cough in people with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis Ended

2023-510249-79-00 Progressive pulmonary fibrosis (PPF) 4 2024-09-10
MLS-101-301: A Randomized, Double-Blind, Placebo Controlled, Parallel Arm, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of … Ended

2023-506425-12-00 Uncontrolled and Resistant Hypertension 5 2024-04-17
Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis Ended

2023-510127-30-00 Relapsing Remitting Multiple Sclerosis (RRMS) 1 2024-04-17
RANDOMIZED, OPEN LABEL, PARALLEL-GROUP, TWO-ARM, MULTICENTER STUDY WITH CLINICAL ENDPOINT COMPARING PRESERVATIVE FREE BIMATOPROST OPHTHALMIC… Ended

2023-504759-28-00 Ocular Hypertension 5 2024-04-05
A study to learn if baxdrostat works at reducing blood pressure and is safe in people with high blood pressure Ended

2023-505499-32-00 Uncontrolled hypertension (uTHN) defined as blood press 5 2024-03-08
MK-0616-013 Ended

2022-502777-42-01 Hypercholesterolemia 5 2024-01-16
Extension Study to Assess Batoclimab in Participants with TED. Ended

2024-512650-21-00 Thyroid Eye Disease (TED) 5 2023-12-13
Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Participants with Moderate to Severe Ulcerative Colitis Ended

2022-503005-38-00 Ulcerative Colitis 4 2023-12-04
Phase 3 Study to Assess Batoclimab in Participants with Active Thyroid Eye Disease. Ended

2024-512648-45-00 Thyroid Eye Disease (TED) 5 2023-11-30
A study to compare how well gadoquatrane works and its safety with an already available contrast agent for MRI in people with known or suspe… Ended

2022-501884-41-00 Contrast enhancement in magnetic resonance imaging for 5 2023-09-29
A study to compare the effects and safety of gadoquatrane with an already used available contrast agent for MRI tests in people with any kno… Ended

2022-501885-24-00 Contrast enhancement in magnetic resonance imaging for 5 2023-09-20
Phase 2b Study to Assess Efficacy and Safety of Batoclimab in Adult Participants with Active CIDP. Ended

2024-512646-42-00 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP 4 2023-06-27
A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults with Cardiomyopathy Ended

2023-506352-24-00 Non-obstructive Hypertrophic Cardiomyopathy 5 2023-04-13
Phase 3 Study to Assess Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants with Generalized Myasth… Ended

2024-512258-91-00 Generalized Myasthenia Gravis (gMG) 5 2023-02-03